1-4 of 4
Camille Rouzaud
Close
Sort by
Journal Articles

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

Guillaume Berton, Bochra Sedaki, Erwann Collomb, Sami Benachour, Michael Loschi, Bilal Mohty, Colombe Saillard, Yosr Hicheri, Camille Rouzaud, Valerio Maisano, Ferdinand Villetard, Evelyne D'Incan Corda, Aude Charbonnier, Jerome Rey, Marie Anne Hospital, Antoine Ittel, Norman Abbou, Raphaelle Fanciullino, Bérengère Dadone-Montaudié, Norbert Vey, Geoffroy Venton, Thomas Cluzeau, Anne Sophie Alary, Sylvain Garciaz
Journal: Blood
Blood (2023) 142 (Supplement 1): 2848.
https://doi.org/10.1182/blood-2023-180733
Published: 2023
Journal Articles

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Marine Duranjou, Cécile Castoldi, Anne Sophie Alary, Yosr Hicheri, Colombe Saillard, Camille Rouzaud, Aude Charbonnier, Bilal Mohty, Evelyne D'Incan, Jerome Rey, Marie Anne Hospital, Raynier Devillier, Norbert Vey, Véronique Gelsi-Boyer, Anne-Catherine Lhoumeau, Anne Murati, Florence Golesi, Marie Joelle Mozziconacci, Antoine Ittel, Sylvain Garciaz
Journal: Blood
Blood (2023) 142 (Supplement 1): 6483.
https://doi.org/10.1182/blood-2023-186086
Published: 2023
Journal Articles

Evaluation of Novel Endpoints As Treatment Outcome in Allogeneic Hematopoietic Stem Cell Transplantation: A Comparison of "Classical" and "Refined" Definition of Graft-Versus Host Disease Free and Relapse Free Survival for Registry-Based Studies

Simona Pagliuca, Antonio M Risitano, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Alban Villate, MD, Rudy Birsen, Camille Rouzaud, Aurelien Sutra del Galy, Nabergoj Mitja, MD, Regis Peffault De Latour, MD PhD, Marie Robin, MD PhD, Gérard Socié, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3311.
https://doi.org/10.1182/blood.V130.Suppl_1.3311.3311
Published: 2017
Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation after Chronic Graft Versus Host Disease and Evaluation of Revised Failure Free Survival in a Retrospective Analysis from Two Referral Centers.

Simona Pagliuca, Flore Sicre De Fontbrune, MD, Antonio M Risitano, MD PhD, David Michonneau, MD PhD, Alban Villate, MD, Rudy Birsen, Camille Rouzaud, Aurelien Sutra del Galy, Nabergoj Mitja, MD, Regis Peffault De Latour, MD PhD, Gérard Socié, MDPhD, Marie Robin, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4578.
https://doi.org/10.1182/blood.V130.Suppl_1.4578.4578
Published: 2017